Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

Meditation as an approach to lessen menopausal symptoms and insomnia in working women undergoing the menopausal transition period: A randomized controlled trial

2020; Elsevier BV; Volume: 8; Issue: 4 Linguagem: Inglês

10.1016/j.aimed.2020.08.003

2212-9596

Caio Fábio Schlechta Portella, Isabel Cristina Espósito Sorpreso, Alan da Silva Menezes de Assis, Luíz Carlos de Abreu, José Maria Soares, Edmund Chada Baracat, Sandra Dircinha Teixeira de Araújo Moraes, Ana Cristina dʼAndretta Tanaka,

Circadian rhythm and melatonin

The objective of this study was to assess the impact of meditation (Raja Yoga meditation) on insomnia and other menopausal symptoms experienced by working women during the menopausal transition period. A randomized clinical trial was conducted with 47 women between the ages of 40 and 55 who worked in three of the National Institute of Social Security units, in the city of Sao Paulo, Sao Paulo, Brazil. Participants were randomized into two groups: an intervention group, who practiced Raja Yoga Meditation and Sleep Hygiene - M + SH (n = 18); and a control group, who practiced only Sleep Hygiene - SH (n = 15) during a period that went from April to July 2013. Eight weekly meetings were held with the participants of both groups. Menopausal symptoms and sleep disturbances were the outcomes analyzed. In relation to the intensity of the insomnia symptom, improvement in relation to time was observed in both groups (M + SH p = 0.001) (SH p = 0.005). The intervention group showed a significant improvement in KMI index (p = 0,024). The control group showed improvement in PSQ total score (p = 0,016). In the comparison between groups ANOVA two-way test showed significant difference (0,026) in KMI, demonstrating that meditation can be relevant for the decrease of climatic symptoms. The results suggest that Raja Yoga meditation may be a non-pharmacological alternative in the control of sleep quality and menopause associated symptoms during late menopausal transition, contributing to the improvement of working women’s quality of life. Registered in the Brazilian Clinical Trials Platform UTN: U1111−1136-0744.